NCT06039085Recruiting
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment
Source: ClinicalTrials.gov · Last updated 7 Apr 2026
Brief summary (registry, in English)
This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 31 Aug 2023
- Start date
- 3 Nov 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Ryan J. Halter
- Diseases
- Prostate cancer
- NCT number
- NCT06039085
What you commit to
- Study type: Observational
- Planned participants: 200
- From 3 Nov 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any condition for which, in the opinion of the investigator, contraindicates study participation.
Other
- Adults with implanted electrical devices such as pacemakers
- Prisoners
- Adults with impaired decision-making capacity
Who the study is looking for
- Clinical diagnosis of prostate cancer requiring RARP.
- Ability to understand and the willingness to sign a written informed consent document.
- Age ≥ 18 years old
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dartmouth Hitchcock Medical Center Coordinator of this site? Confirm its status | Lebanon | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.